Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FRa)-positive cancer Meeting Abstract


Authors: Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; Matulonis, U. A.; O'Malley, D.
Abstract Title: Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FRa)-positive cancer
Meeting Title: ESMO Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 7
Meeting Dates: 2022 Sep 9-13
Meeting Location: Paris, France
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: S822
End Page: S823
Language: English
ACCESSION: WOS:000866211600597
DOI: 10.1016/j.annonc.2022.07.733
PROVIDER: wos
Notes: Meeting Abstract: 605P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jason Konner
    155 Konner